Minerva Neurosciences (NERV) Misses Q2 EPS by 12c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($1.09), $0.12 worse than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Gulfport Energy and Mobility Global to join S&P SmallCap 600
• Deutsche Bank Upgrades Softbank Group Corp. (9984:JP) (SFTBY) to Buy
• GameStop 'remains focused on advancing' proposed eBay deal, offers adjusted EBITDA guidance - Filing